Navigation Links
Stiefel Launches Most-Prescribed BPO Wash Formulations Over-the-Counter
Date:2/4/2011

RESEARCH TRIANGLE PARK, N.C., Feb. 4, 2011 /PRNewswire/ -- Stiefel, a GSK company, today announced the launch of the most-prescribed BPO Acne Wash formulations for over-the-counter (OTC) use in the United States. The launch will occur in the technical exhibit at the American Academy of Dermatology annual meeting in New Orleans. Indicated for the treatment of acne, Stiefel will market two products OTC under the PanOxyl® Brand.  PanOxyl® Acne Creamy Wash will be available in 4% BPO and 8% BPO.  

PanOxyl® 4% and 8% BPO Acne Creamy Washes feature a patented delivery system including Dimethyl Isosorbide (DMI) that solubilizes BPO and greatly reduces particulate-based skin irritation and inflammation commonly experienced with conventional BPO formulations.  Both products are thick, creamy formulations which provide excellent efficacy and rapid reduction in acne lesions.  

"Stiefel's Creamy Wash formulations have been physician favorites for several years," said Shayne Sundholm, vice president, U.S. Non Prescription Dermatology, Stiefel.  "And we are excited to be able to offer them to a larger number of consumers through the retail market."  

A comprehensive marketing campaign directed toward dermatologists and pharmacists will communicate details of the new PanOxyl® 4% and 8% BPO Acne Creamy Washes.  Product will be available for shipment in May 2011.  

PanOxyl® Acne Management product line offers different formulations for the treatment and prevention of acne on the face, chest and back.  

www.panoxyl-skincare.com

About Stiefel, a GSK company  

Stiefel, a GSK company, is committed to advancing dermatology and skin science around the world in order to help people better achieve healthier skin.  Stiefel's dedication to innovation, along with its focus on pharmaceutical, over-the-counter and aesthetic dermatology products, has established Stiefel as a world leader in the skin health industry.  To learn more about Stiefel, visit www.stiefel.com


'/>"/>
SOURCE Stiefel, a GSK company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
2. Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam
3. RoundTable Healthcare Partners Names Charles W. Stiefel as Senior Advisor
4. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
5. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
6. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
7. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
8. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
9. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
10. Premier Micronutrient Launches Supplement for Hearing Health
11. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical Center ... in Nashville , Tennesse have been ... Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim ... long-term reflux control by restoring normal function to the ... million people in the United States ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... Life of Purpose Treatment ... Florida. The event will be held at 7:30 pm on May 10th at the ... Drew Copeland of Sister Hazel, will support the UF Collegiate Recovery Community (UFCRC). The ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, a pre-clinical stage ... the treatment of Acute Ischemic Stroke (AIS), today announced it has appointed Creganna ... advances towards regulatory and clinical phases. , "This is another important step for ...
(Date:4/23/2017)... York, New York (PRWEB) , ... April 23, 2017 , ... ... begin to change. So is the process rendered in my Art and Music. These ... materials, nature, light, and silence the boundary of mystery culminate to the ultimate singularity.", ...
(Date:4/22/2017)... ... , ... Ecommerce sales have grown every year since the 1990’s, with 2016 ... consequences of rapid innovation and growth are often neglected in the name of progress. ... and individual’s job to give something back to the planet that provides the resources ...
(Date:4/22/2017)... ... April 22, 2017 , ... PharmacyChecker.com released ... save an average of 70% when buying medication online from Canadian pharmacies verified ... when purchasing from other countries. The report (chart below) compares U.S. and foreign ...
Breaking Medicine News(10 mins):